MedPath

The Effect of Electroacupuncture on Obesity

Phase 2
Conditions
Obesity
Registration Number
NCT01102075
Lead Sponsor
Kyunghee University Medical Center
Brief Summary

The purpose of this study is to determine whether electroacupuncture is effective on waist circumference in obesity.

Detailed Description

Many studies have reported on the beneficial effects of acupuncture for obesity, although some negative reports also existed.(Wang F. et al. 2008)Recently conducted systematic review of Pittler and Ernst reported that there was insufficient, but not conclusive evidence to support the efficacy of acupuncture and acupressure for weight loss. However, most of these studies had methodological limitation, such as lack of adequate control group or unclear specific effect of electroacupuncture alone because auricular acupuncture was administered as well. In this sudy, we had three-arm randomized controlled trial(with sham control group) to investigate whether electroacupuncture is effective in the treatment of obesity.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Waist circumference: Male>= 90 cm, Female >= 85 cm
  • BMI over than 25kg/m2
Exclusion Criteria
  • Secondary obesity caused by endocrine disease, e.g., polycystic ovary syndrome, diabetes mellitus, Cushing's syndrome, hypothyroidism etc.
  • Heart disease,e.g.,arrhythmia, heart failure, myocardial infarction, and patient with pacemaker
  • Hypertension, hyperlipidemia or hypercholesterinemia patients on medication
  • Stroke or otherwise unable to exercise
  • Pregnant or lactating women
  • Childbirth within 6 months
  • Management for weight control within 3 months
  • Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
waist circumferenceAt 5 weeks (post treatment)
Secondary Outcome Measures
NameTimeMethod
Thickness of abdominal subcutaneous fatAt 8weeks after first treatment (follow up)

Thickness of abdominal subcutaneous fat was measured by digital skinfold caliper(FatTrack).

Waist hip ratioAt 8weeks after first treatment (follow up)
Body Mass IndexAt 8weeks after first treatment (follow up)

Body Mass Index was measured by Inbody 720

Body fat ratioAt 8weeks after first treatment (follow up)

Body fat ratio was measured by Inbody 720

Visceral Fat AreaAt 8weeks after first treatment (follow up)

Visceral Fat Area was measured by Inbody 720

Body weightAt 8weeks after first treatment (follow up)

Body weight was measured by Inbody 720

Obesity degreeAt 8weeks after first treatment (follow up)

Obesity degree was measured by Inbody 720

Bulimia Test RevisedAt 5weeks (post treatment)
Korean version of Obesity-related QOL scaleAt 5weeks (post treatment)
Body Shape QuestionnaireAt 5weeks (post treatment)

Trial Locations

Locations (1)

Kyunghee University Medical Center

🇰🇷

Seoul, Hoegi-dong, Dongdaemun-gu, Korea, Republic of

Kyunghee University Medical Center
🇰🇷Seoul, Hoegi-dong, Dongdaemun-gu, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.